6Friedrich K,Porta Robert A,Wolfeb,et al.Random Sample (DOPPS) versus census-baseb (Registry)approaches to Kidney disease research[J].Blood Purification,2003,12(6):21.
7Toto R, Shuhz P, Raij L, et al. Efficacy and tolerability of losartan in hypertensive patients with renal impairment. Collaborative Group. Hypertension, 1998, 31: 684-691.
8Mitsuhashi H, Tamura K, Yamauchi J, et al. Effect of losartan on ambulatory short-term blood pressure variability and cardiovascular remodeling in hypertensive patients on hemodialysis. Atherosclerosis, 2009, 207: 186-190.
9Ichihara A, l-layashi M, Kaneshiro Y, et al. Low doses of losartan and trandolapril improve arterial stiffness in hemodia- lysis patients. Am J Kidney Dis, 2005, 45: 866-874.
10Shibasaki Y, Nishiue T, Masaki H, et al. Angiotensin I type 1 antagonist suppress left ventricular hypertrophy and myocardial fibrosis in patient with end stage renal disease (ESRD). Nihon Rinsho,2002, 60: 1992-1998.
